Adia Med Inc. Announces Adia Labs Expansion of Regenerative Product Line
Winter Park, Florida--(Newsfile Corp. - September 29, 2026) - Adia Med Inc. (OTCQB: ADIA), a regenerative medicine company focused on stem cell therapies, biologics, and physician-supervised investigational research, today announced that its laboratory subsidiary, Adia Labs LLC, has expanded its product portfolio with three new research-use offerings: Adia30M, AdiaClear, and AdiaEXO.To view an enhanced version of this graphic, please...
Plan Gratis · Plus 29 CA$ o Pro 99 CA$/mes


